This is a recovery-plus-expansion setup, not a moonshot. UiPath already has mature software, strong
gross margins, positive cash generation, and low capital needs. The upside comes from becoming the governed execution layer for agents, robots, documents, and testing inside large accounts, while cross-sell and partner distribution deepen wallet share. I assume only a modest
rerating because bundled suites still cap the ceiling.